HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization (Q38474353)

3 September 2017

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization (English)

1 reference

3 September 2017

1 reference

Ross JS

1

1 reference

3 September 2017

Sheehan C

2

1 reference

3 September 2017

Hayner-Buchan AM

3

1 reference

3 September 2017

Ambros RA

4

1 reference

3 September 2017

Kallakury BV

5

1 reference

3 September 2017

Kaufman R

6

1 reference

3 September 2017

Fisher HA

7

1 reference

3 September 2017

Muraca PJ

8

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 July 1997

1 reference

3 September 2017

1 reference

3 September 2017

28

1 reference

3 September 2017

7

1 reference

3 September 2017

827-833

1 reference

describes a project that uses

3 September 2017

fluorescence in situ hybridization

1 reference

Changes in prostate cancer incidence and treatment in USA

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Oncogene amplifications in early-stage human prostate carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Gene amplifications in advanced-stage human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Trisomy 7: a potential cytogenetic marker of human prostate cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Numerical abnormalities of chromosome 7 in human prostate cancer detected by fluorescence in situ hybridization (FISH) on paraffin-embedded tissue sections with centromere-specific DNA probes

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH).

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH).

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

Overexpression of HER2/neu oncogene in human pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2897%2990157-X

7 January 2021

10.1016/S0046-8177(97)90157-X

Identifiers

DOI

1 reference

3 September 2017

1 reference